Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

DocGo Inc

Healthcare US DCGO

0.5067USD
-0.0267(5.01%)

Last update at 2026-06-23T20:02:00Z

Day Range

0.500.55
LowHigh

52 Week Range

2.7810.82
LowHigh

Fundamentals

  • Previous Close 0.53
  • Market Cap320.95M
  • Volume1083267
  • P/E Ratio15.80
  • Dividend Yield-%
  • EBITDA55.06M
  • Revenue TTM703.37M
  • Revenue Per Share TTM6.78
  • Gross Profit TTM 154.72M
  • Diluted EPS TTM0.20

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax 22.78M 19.80M -14.63177M -21.19101M
Minority interest -3.84129M -4.56427M 0.44M 1.03M
Net income 34.58M 23.74M -14.79921M -21.23804M
Selling general administrative 112.18M 78.80M 38.66M 27.18M
Selling and marketing expenses 4.76M 4.76M 0.75M 1.37M
Gross profit 154.72M 109.75M 31.35M 13.19M
Reconciled depreciation 10.57M 7.07M 5.51M 4.18M
Ebit 21.83M 10.49M -14.75768M -20.76273M
Ebitda 34.21M 17.56M -9.58057M -16.69806M
Depreciation and amortization 12.38M 7.07M 5.18M 4.06M
Non operating income net other -0.98748M - - -
Operating income 21.83M 10.49M -14.75768M -20.76273M
Other operating expenses 418.68M 303.36M 108.85M 69.06M
Interest expense 0.76M 763030.00M 0.90M 0.72M
Tax provision -7.96132M 0.62M 0.17M 0.05M
Interest income - - - -
Net interest income 0.76M -0.76303M -0.20463M -0.54587M
Extraordinary items - - - -
Non recurring 11.70M 3.91M - -
Other items - - - -
Income tax expense -7.96132M 0.62M 0.17M 0.05M
Total revenue 440.52M 318.72M 94.09M 48.30M
Total operating expenses 132.89M 94.39M 46.10M 33.95M
Cost of revenue 285.79M 208.97M 62.74M 35.11M
Total other income expense net 0.95M 9.31M 0.13M -0.42828M
Discontinued operations - - - -
Net income from continuing ops 30.74M 19.18M -14.79921M -21.23804M
Net income applicable to common shares 34.58M 23.74M -14.35994M -20.21004M
Preferred stock and other adjustments - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 490.45M 393.28M 309.60M 100.17M 100.96M
Intangible assets 37.68M 22.97M 10.68M 10.67M 9.97M
Earning assets - - - - -
Other current assets 17.50M 6.27M 2111656.00M 1.15M 1.24M
Total liab 185.28M 114.35M 82.55M 33.23M 21.60M
Total stockholder equity 300.79M 273.23M 219.58M 55.00M 68.47M
Deferred long term liab - - - - -
Other current liab 22.14M 72.85M 0.74M 0.05M 5.12M
Common stock 0.01M 0.01M 0.01M - -
Capital stock 0.01M 0.01M 0.01M 0.00000M 0.00000M
Retained earnings -21.39431M -28.97222M -63.55671M -87.30047M -72.94053M
Other liab - - 13.52M - -
Good will 47.54M 38.90M 8.69M 6.61M 6.31M
Other assets - 20.36M 7.38M 3.36M 5.13M
Cash 59.29M 157.34M 175.54M 32.42M 47.74M
Cash and equivalents - - - - -
Total current liabilities 170.12M 100.16M 57.88M 23.50M 9.73M
Current deferred revenue 96.81M - 35.95M 15.33M -
Net debt -12.78900M -137.42100M -159.02636M -18.52698M -32.20358M
Short term debt 31.34M 5.72M 5.36M 4.16M 3.67M
Short long term debt 25.03M 0.66M 0.63M 0.66M 0.56M
Short long term debt total 46.50M 19.91M 16.51M 13.89M 15.54M
Other stockholder equity 320.69M 301.45M 283.16M 142.35M 141.66M
Property plant equipment - 21.26M 26.24M 21.10M 20.41M
Total current assets 338.87M 271.08M 256.03M 58.42M 59.14M
Long term investments 0.55M 0.60M 0.59M - -
Net tangible assets - 211.36M 200.22M 37.71M 52.20M
Short term investments 553572.45M - - - -
Net receivables 262.08M 103.00M 78.38M 24.85M 10.16M
Long term debt 0.04M 1.24M 14.82M 0.59M 0.75M
Inventory 0.00000M 4.48M -2111653.88834M - -
Accounts payable 19.83M 21.58M 15.83M 3.95M 0.95M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - 5.70M 7.48M - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 1.48M 0.74M -0.03250M -0.04854M -0.24488M
Additional paid in capital - - - - -
Common stock total equity - 0.01M 0.01M - -
Preferred stock total equity - - - - -
Retained earnings total equity - -28.97222M -63.55671M - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 15.50M 10.40M 7.38M 3.36M 5.13M
Deferred long term asset charges - 9.96M - - -
Non current assets total 151.58M 122.20M 53.57M 41.75M 41.82M
Capital lease obligations 21.43M 18.01M 14.58M 12.63M 14.22M
Long term debt total - 1.24M 14.82M - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -38.44797M -0.65588M -6.04002M -2.97128M
Change to liabilities -2.32676M 11.88M 3.01M -0.10067M
Total cashflows from investing activities -38.44797M -8.58919M -6.04002M -2.97128M
Net borrowings -0.97060M -2.82113M -2.27809M -3.19782M
Total cash from financing activities -6.17982M 155.21M -0.81209M 56.34M
Change to operating activities -8.39713M 17.31M 9.54M 2.15M
Net income 30.74M 19.18M -14.79921M -21.23804M
Change in cash -14.99666M 144.65M -17.31046M 38.91M
Begin period cash flow 179.11M 34.46M 51.77M 12.85M
End period cash flow 164.11M 179.11M 34.46M 51.77M
Total cash from operating activities 28.87M -1.94742M -10.65469M -14.20590M
Issuance of capital stock 0.00000M 178.10M 0.00000M 49.04M
Depreciation 10.57M 7.07M 5.51M 4.18M
Other cashflows from investing activities -35.24974M -0.05050M -0.05050M -0.05050M
Dividends paid - 8.63M - -
Change to inventory - - - -
Change to account receivables -8.41579M -57.99661M -16.15395M -2.27545M
Sale purchase of stock -3.73171M -0.47933M - -
Other cashflows from financing activities -1980583.51151M -2.96678M 1.47M 59.54M
Change to netincome 2.10M -3.96096M 1.80M 2.05M
Capital expenditures 5.50M 6.66M 6.32M 3.80M
Change receivables -8.41579M -57.99661M - -
Cash flows other operating -0.56375M -0.53780M - -
Exchange rate changes - -0.02141M - -
Cash and cash equivalents changes -15.75789M 144.65M - -
Change in working capital -13.17562M -28.80177M -3.60512M -0.22421M
Stock based compensation 8.05M 1.38M 0.69M 0.46M
Other non cash items 2.64M -0.14267M -0.30000M 0.15M
Free cash flow 23.37M -8.60496M -16.97094M -18.00881M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
DCGO
DocGo Inc		 -0.0267 5.01% 0.51 15.80 13.04 0.54 1.13 0.52 10.38
HCA
HCA Healthcare, Inc.		 9.93 2.63% 386.92 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 0.18 1.59% 11.48 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc		 -0.15 3.30% 4.40 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc		 - -% 5.85 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

DocGo Inc

35 West 35th Street, New York, NY, United States, 10001

Key Executives

Name Title Year Born
Mr. Stan Vashovsky Co-Founder, Chairman & CEO 1972
Mr. Anthony Capone Pres 1987
Mr. Andre Oberholzer CPA Chief Financial Officer 1958
Mr. Ely D. Tendler Gen. Counsel, Sec. & Director 1968
Mr. Lee Bienstock Chief Operating Officer 1984
Mr. Stephen Sugrue Chief Compliance Officer 1972
Mr. Ben Sherman EVP of Corp. Devel. NA
Ms. Rosemarie Milano VP of HR NA
Mr. Norman Rosenberg Chief Financial Officer of Ambulnz Holdings, LLC 1969
Dr. Mark Merlin Chief Medical Officer of Ambulnz Holdings, LLC 1968

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.